Viewing StudyNCT05410717

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 5:44 PM
Last Modification Date: 2024-10-26 @ 2:34 PM
Study NCT ID: NCT05410717
Status: RECRUITING
Last Update Posted: 2024-06-25
First Post: 2022-06-05
Brief Title: CLDN6GPC3MesothelinAXL-CAR-NK Cell Therapy for Advanced Solid Tumors
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Organization: Second Affiliated Hospital of Guangzhou Medical University
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
CAR NK
Stage IV Ovarian Cancer
Testis Cancer Refractory
Endometrial Cancer Recurrent
Keywords:
Name View
CTLA1 antibody View
Solid tumor View
Claudin6 View
CAR NK View
GPC3 View
Mesothelin View
AXL View
Cannabidiol View
Nicotinamide adenine dinucleotide View
IL7 View
CCL19 View
PD1 antibody View
PDL1 antibody View